US 12,109,050 B2
Method and system for acquiring data for assessment of cardiovascular disease
Tuhin Sinha, Burlingame, CA (US); Ian Eslick, Burlingame, CA (US); and Alan Leggitt, Burlingame, CA (US)
Assigned to Riva Health, Inc., Burlingame, CA (US)
Filed by Riva Health, Inc., Burlingame, CA (US)
Filed on Nov. 29, 2023, as Appl. No. 18/522,806.
Application 18/522,806 is a division of application No. 17/588,080, filed on Jan. 28, 2022, granted, now 11,872,061.
Application 17/588,080 is a continuation of application No. 16/538,361, filed on Aug. 12, 2019, granted, now 11,266,356, issued on Mar. 5, 2022.
Application 16/538,361 is a continuation of application No. 15/357,621, filed on Nov. 21, 2016, granted, now 10,420,515, issued on Sep. 24, 2019.
Application 15/357,621 is a continuation in part of application No. 15/183,285, filed on Jun. 15, 2016, granted, now 10,420,475, issued on Sep. 24, 2019.
Claims priority of provisional application 62/175,971, filed on Jun. 15, 2015.
Claims priority of provisional application 62/257,888, filed on Nov. 20, 2015.
Prior Publication US 2024/0099667 A1, Mar. 28, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/02 (2006.01); A61B 5/00 (2006.01); A61B 5/024 (2006.01); G06N 20/00 (2019.01); G16H 20/10 (2018.01); G16H 20/70 (2018.01); G16H 30/40 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 5/0205 (2006.01); A61B 5/021 (2006.01)
CPC A61B 5/7275 (2013.01) [A61B 5/0077 (2013.01); A61B 5/02427 (2013.01); A61B 5/02438 (2013.01); A61B 5/7221 (2013.01); G06N 20/00 (2019.01); G16H 20/10 (2018.01); G16H 20/70 (2018.01); G16H 30/40 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 5/02055 (2013.01); A61B 5/02108 (2013.01); A61B 5/4812 (2013.01); A61B 5/6826 (2013.01); A61B 5/6843 (2013.01); A61B 5/7239 (2013.01); A61B 5/7264 (2013.01); A61B 2576/00 (2013.01)] 4 Claims
OG exemplary drawing
 
1. A method comprising:
a) determining a time series of data of a body region of the individual at a device coupled to an individual;
b) determining a mapping of the body region of the individual at the device for each of a set of frames of the time series of data;
c) determining an active pixel set for each of the set of frames of the time series of data;
d) aggregating at least one of the mappings or the active pixel sets of the set of frames of the time series of data into an aggregated time series of data; and
e) determining a health biomarker value of the individual based upon the aggregated time series.